Table 3.
2-wk posttreatment difference from baseline |
|||||
Assessment tool | Dose level | No. | Median (Min, Q1, Q3, Max) | ||
EPIC-26: Bowel* | 3.6 Gy × 15 fractions | 6 | −4.2 (−50.0, −20.8, 0, 8.3) | ||
4.7 Gy × 10 fractions | 6 | −33.3 (−87,5, −54.2, 0, 3.3) | |||
7.1 Gy × 5 fractions | 12 | −31.3 (−75.0, −54.2, −14.6, 8.3) | |||
EPIC-26: Urinary irritative* | 3.6 Gy × 15 fractions | 6 | −6.3 (−25, −18.8, 0, 6.3) | ||
4.7 Gy × 10 fractions | 6 | 0 (−6.3, −6.3, 0, 12.5) | |||
7.1 Gy × 5 fractions | 12 | −6.3 (−56.3, −18.8, −3.1, 12.5) | |||
EPIC-26: Urinary incontinence* | 3.6 Gy × 15 fractions | 6 | 4.1 (−12.5, −8.3, 8.3, 8.3) | ||
4.7 Gy × 10 fractions | 6 | 3.1 (0, 0, 6.3, 14.5) | |||
7.1 Gy × 5 fractions | 12 | 3.1 (−31.3, −11.5, 6.3, 62.8) | |||
IPSS total score† | 3.6 Gy × 15 fractions | 6 | 2 (−3, −3, 7, 9) | ||
4.7 Gy × 10 fractions | 6 | 1 (−1, −1, 3, 4) | |||
7.1 Gy × 5 fractions | 12 | 2 (−3, 0, 3, 14) | |||
6-wk posttreatment difference from baseline |
10-wk posttreatment difference from baseline |
6-mo posttreatment difference from baseline |
|||
No. | Median (Min, Q1, Q3, Max) | No. | Median (Min, Q1, Q3, Max) | No. | Median (Min, Q1, Q3, Max) |
6 | 0 (−25.0, 0, 4.2, 8.3) | 6 | 0 (−16.7, 0, 8.3, 8.3) | 6 | −2.1 (−4.2, −4.2, 8.3, 12.5) |
6 | −6.3 (−37.5, −25, 0, 12.5) | 6 | −2.1 (−25.0, −12.5, 0, 16.7) | 6 | −4.2 (−8.3, −8.3, 0, 0) |
12 | −16.7 (−50.0, −31.3, −2.1, 8.3) | 11 | −16.7 (−54,2, −20.8, 0, 8.3) | 12 | −6.3 (−41.7, −12.5, 0, 11.7) |
6 | −6.3 (−12.5, −6.3, −6.3, 31.3) | 6 | 0 (−12.5, 0, 6.3, 37.5) | 6 | 0 (−6.3, 0, 12.5, 37.5) |
6 | 0 (−6.3, 0, 6.3, 18.8) | 6 | 0 (−6.3, −6.3, 6.3, 25) | 6 | 3.1 (0, 0, 6.3, 6.3) |
12 | −6.3 (−43.8, −12.5, 0, 6.3) | 11 | 0 (−6.3, −6.3, 6.3, 25) | 12 | 0 (−50, −6.3, 6.3, 25) |
6 | 1 (−27, −12.5, 8.3, 33.3) | 6 | 6.3 (0, 6.3, 22.8, 41.8) | 6 | 0 (−33.3, −14.5, 45.8, 60.5) |
6 | 0 (−8.3, −6.3, 6.3, 22.8) | 6 | 1 (−14.5, 0, 6.3, 29) | 6 | −7.3 (−20.8, −16.8, 0, 0) |
12 | 2 (−21, 0, 9.4, 35.8) | 11 | 0 (−12.5, −6.3, 6.3, 27) | 12 | −3.1 (−21, −10.4, 21.9, 69) |
6 | 2 (−7, −3, 5, 7) | 6 | −1.5 (−9, −7, 0, 2) | 6 | 0.5 (−9, −6, 3, 4) |
6 | 2 (−2, 0, 3, 3) | 6 | 2 (−14, 0, 3, 4) | 6 | 1 (−3, −1, 3, 3) |
12 | 1 (−9, −2.5, 7.5, 14) | 11 | 0 (−6, 0, 4, 9) | 12 | 2 (−7, −2.5, 4.5, 18) |
Abbreviations: EPIC = Expanded Prostate Cancer Index; IPSS = International Prostate Symptom Score; max = maximum; Min = minimum.
EPIC-26 (range 0–100). The higher the score, the better the patient is doing.
IPSS (range 0–35). Scores 1 to 7 = mild, 8 to 19 = moderate, 20 to 35 = severe prostate symptoms.